The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma

Niels Weinhold, David C Johnson, Daniel Chubb, Bowang Chen, Asta Försti, Fay J Hosking, Peter Broderick, Yussanne P Ma, Sara E Dobbins, Dirk Hose, Brian A Walker, Faith E Davies, Martin F Kaiser, Ni L Li, Walter A Gregory, Graham H Jackson, Mathias Witzens-Harig, Kai Neben, Per Hoffmann, Markus M NöthenThomas W Mühleisen, Lewin Eisele, Fiona M Ross, Anna Jauch, Hartmut Goldschmidt, Richard S Houlston, Gareth J Morgan, Kari Hemminki

Onderzoeksoutput: Articlepeer review

83 Citaten (Scopus)

Samenvatting

A number of specific chromosomal abnormalities define the subgroups of multiple myeloma. In a meta-analysis of two genome-wide association studies of multiple myeloma including a total of 1,661 affected individuals, we investigated risk for developing a specific tumor karyotype. The t(11;14)(q13;q32) translocation in which CCND1 is placed under the control of the immunoglobulin heavy chain enhancer was strongly associated with the CCND1 c.870G>A polymorphism (P = 7.96 × 10(-11)). These results provide a model in which a constitutive genetic factor is associated with risk of a specific chromosomal translocation.

Originele taal-2English
Pagina's (van-tot)522-525
Aantal pagina's4
TijdschriftNature Genetics
Volume45
Nummer van het tijdschrift5
DOI's
StatusPublished - 2013

Vingerafdruk

Duik in de onderzoeksthema's van 'The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma'. Samen vormen ze een unieke vingerafdruk.

Citeer dit